315 related articles for article (PubMed ID: 11014642)
21. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
[TBL] [Abstract][Full Text] [Related]
22. A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody.
Stegall MD; Gloor J; Winters JL; Moore SB; Degoey S
Am J Transplant; 2006 Feb; 6(2):346-51. PubMed ID: 16426319
[TBL] [Abstract][Full Text] [Related]
23. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
[TBL] [Abstract][Full Text] [Related]
24. Highly Sensitized Patients: Miami Transplant Institute Experience.
Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
[TBL] [Abstract][Full Text] [Related]
25. Successful transplantation across positive B-cell cross-match in deceased donor renal transplants.
Goh A; Oei E; Vathsala A
Transplant Proc; 2012 Jan; 44(1):193-9. PubMed ID: 22310613
[TBL] [Abstract][Full Text] [Related]
26. Desensitization Protocol in Recipients of Deceased Kidney Donor With Donor-Specific Antibody-Low Titers.
Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Avila Bernabeu A; Crespo Albiach J; Molina Vila P; Beltrán Catalan S; Pallardó Mateu L
Transplant Proc; 2016 Nov; 48(9):2880-2883. PubMed ID: 27932097
[TBL] [Abstract][Full Text] [Related]
27. New treatments for acute humoral rejection of kidney allografts.
Venetz JP; Pascual M
Expert Opin Investig Drugs; 2007 May; 16(5):625-33. PubMed ID: 17461736
[TBL] [Abstract][Full Text] [Related]
28. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
Yuan XP; Wang CX; Gao W; Fu Q; He XS
Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
[TBL] [Abstract][Full Text] [Related]
29. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
[TBL] [Abstract][Full Text] [Related]
30. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients.
Zachary AA; Montgomery RA; Ratner LE; Samaniego-Picota M; Haas M; Kopchaliiska D; Leffell MS
Transplantation; 2003 Nov; 76(10):1519-25. PubMed ID: 14657698
[TBL] [Abstract][Full Text] [Related]
31. Successful living donor renal transplantation despite ABO incompatibility and a positive crossmatch.
Kayler LK; Colombe B; Farber JL; Lacava D; Dafoe DC; Burke JF; Francos GC; Ratner LE
Clin Transplant; 2004 Dec; 18(6):737-42. PubMed ID: 15516254
[TBL] [Abstract][Full Text] [Related]
32. A novel post-transplant alloantibody surveillance and intervention strategy that improves graft outcomes in sensitized renal transplant recipients.
Kimball PM; King A
Clin Transpl; 2011; ():369-72. PubMed ID: 22755433
[TBL] [Abstract][Full Text] [Related]
33. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of cellular and humoral immunity in a successful case of positive crossmatch kidney transplantation: a case report.
Tanimine N; Ide K; Yamashita M; Tanaka Y; Igarashi Y; Banshodani M; Tazawa H; Basnet NB; Doskali M; Onoe T; Tashiro H; Ohdan H
Transplant Proc; 2011; 43(6):2411-4. PubMed ID: 21839279
[TBL] [Abstract][Full Text] [Related]
35. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation.
Burns JM; Cornell LD; Perry DK; Pollinger HS; Gloor JM; Kremers WK; Gandhi MJ; Dean PG; Stegall MD
Am J Transplant; 2008 Dec; 8(12):2684-94. PubMed ID: 18976305
[TBL] [Abstract][Full Text] [Related]
36. [Kidney transplantation in highly sensitized patients].
Boratyńska M
Postepy Hig Med Dosw (Online); 2005; 59():377-85. PubMed ID: 16106239
[TBL] [Abstract][Full Text] [Related]
37. Successful living related kidney transplantation across an anti-donor HLA antibody.
Ben-Youssef R; Iwaki Y; Baron P; Franco E; Rowsell E; Buckert L; Ojogho O
Transplant Proc; 2006 Jun; 38(5):1280-2. PubMed ID: 16797281
[TBL] [Abstract][Full Text] [Related]
38. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
[TBL] [Abstract][Full Text] [Related]
39. Acute antibody-mediated rejection in paediatric renal transplant recipients.
Kranz B; Kelsch R; Kuwertz-Bröking E; Bröcker V; Wolters HH; Konrad M
Pediatr Nephrol; 2011 Jul; 26(7):1149-56. PubMed ID: 21461632
[TBL] [Abstract][Full Text] [Related]
40. Effects of Two Preemptive Post-transplant Desensitization Regimens Upon Renal Allograft Survival and DSA Elaboration.
Kimball PM; McDougan FA; King A
Clin Transpl; 2014; ():197-203. PubMed ID: 26281145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
